Project conducted by: Jonathan
Client: One of the largest US biotech companies
Objective: Determine whether company should enter the heart and lung post-transplant monitoring space.
Jonathan identified the most appropriate KOLs to collaboratively conduct studies with, negotiated and closed relevant contracts, designed the respective studies with the clinical operations team, and co-led data analysis.
Other Deliverables:
Market research
Competition analysis
Ad boards
Upstream marketing, market fit
Financial forecasting
Product positioning, marketing collateral, clinical adoption potential
Outcome: Company entered the post-transplant monitoring space for both heart and lung and has been executing well in this space.